DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Vivo Capital, LLC
Vivo Capital, LLC
both early and growth/opportunity families, reported GAV $6,018M
Importance
73
high
Active deployment
55
elevated
Emerging
0
low
Completeness
69
high
Freshness
99
high
Research priority
25
moderate
Identity and regulatory footprint
- Headquarters
- Palo Alto, CAadviserinfo.sec.gov
- Office address
- 192 LYTTON AVENUE, Palo Alto, CA, 94301adviserinfo.sec.gov
- Business phone
- 650-688-0818adviserinfo.sec.gov
- Website
- HTTP://VIVOCAPITAL.COM/
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 16 (6 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $6.5Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $6.1Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 62
- business phone
- 650-688-0818adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
76 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech
- Stages
- not stated or not yet read
- Geography
- global
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series d plus 100%
Stage at first entry
series d plus 100%
Sectors
unknown 89%Biotechnology 7%Pharmaceuticals 3%Agriculture 1%
lead rate 100%follow-on rate 0%new logos, 12 months 76
Funds and vehicles
15 reported, 14 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Vivo Co-Invest (c), L.P. | SPV or co-invest vehicle · ADV: Private Equity Fund | 2024 adv first reported | Early deployment | $150M Sep 19, 2024 | 2 | $0 | Oct 27, 2023 |
| Vivo Opportunity Fund Holdings, L.P. | Opportunity fund · ADV: Other Private Fund | 2023 adv first reported | Active deployment | $1.0B Sep 19, 2024 | 65 | unknown | unknown |
| Vivo Capital Fund X, L.P. | Fund · ADV: Private Equity Fund | 2023 form d first sale | Fundraising | $548M Sep 19, 2024 | 16 | $717M | Jan 20, 2026 |
| Vivo Innovation Fund II Holdings, L.P | Fund | 2023 adv first reported | Active deployment | $340M Sep 19, 2024 | 35 | $0 | Dec 16, 2021 |
| Vivo Asia Opportunity Fund Holdings, L.P. | Opportunity fund · ADV: Other Private Fund | 2023 adv first reported | Active deployment | $118M Sep 19, 2024 | 21 | unknown | unknown |
| Vivo Co-Invest (s), L.P. | SPV or co-invest vehicle | 2023 adv first reported | Active deployment | $50.0M Sep 19, 2024 | 1 | $0 | Apr 13, 2022 |
| Vivo Opportunity Co-Invest, L.P. | SPV or co-invest vehicle · ADV: Other Private Fund | 2020 adv first reported | Mature | $81.5M Sep 19, 2024 | 2 | unknown | unknown |
| Vivo Super Viii Limited | Fund | 2019 adv first reported | Mature | $225M Sep 19, 2024 | 6 | unknown | unknown |
| Vivo Capital Fund Ix, L.P. | Fund · ADV: Private Equity Fund | 2018 form d first sale | Harvest | $2.6B Sep 19, 2024 | 46 | $1.4B of $1.4B | Oct 30, 2019 |
| Vivo Panda Fund, LP | Fund | 2016 form d first sale | Harvest | $74.7M Sep 19, 2024 | 12 | $100M of $100M | Jun 2, 2016 |
| Vivo Capital Surplus Fund Viii, L.P. | Fund · ADV: Private Equity Fund | 2015 adv first reported | Harvest | $84.1M Sep 19, 2024 | 9 | unknown | unknown |
| Vivo Capital Fund Viii, L.P. | Fund · ADV: Private Equity Fund | 2014 form d first sale | Harvest | $609M Sep 19, 2024 | 59 | $601M of $601M | Feb 5, 2015 |
| Vivo Ventures VII Affiliates Fund, LP | Feeder or parallel | 2011 form d first sale | Harvest | $1.2M Sep 19, 2024 | 33 | $6.4M of $6.4M | Jan 3, 2012 |
| Vivo Ventures Fund VII, LP | Fund | unknown | Unknown | $51.3M Sep 19, 2024 | 45 | $0 of $350M | Sep 6, 2011 |
| Vivo Ventures Fund Cayman VII, LP | Feeder or parallel | unknown | Unknown | $39.7M Sep 19, 2024 | 13 | unknown | unknown |
| Vivo Asia Opportunity Fund, L.P. | Opportunity fund · ADV: Private Equity Fund | 2022 adv first reported | Wound down | $105M Mar 31, 2022 | 3 | unknown | unknown |
| Vivo Innovation Fund II, L.P. | Fund | 2021 adv first reported | Wound down | $209M Mar 31, 2022 | 11 | unknown | unknown |
| Vivo Opportunity Co-Invest (w), L.P. | SPV or co-invest vehicle · ADV: Private Equity Fund | 2020 adv first reported | Wound down | $17.1M Mar 31, 2021 | 3 | unknown | unknown |
| Vivo Opportunity Fund, L.P. | Opportunity fund · ADV: Private Equity Fund | 2018 adv first reported | Wound down | $656M Mar 31, 2022 | 41 | unknown | unknown |
| Vivo Ventures Fund VI, LP | Fund | unknown | Wound down | $4.8M Apr 28, 2023 | 52 | unknown | unknown |
| Biotechnology Development Fund II, LP | Fund | unknown | Wound down | $2.3M Nov 22, 2019 | 23 | unknown | unknown |
| Biotechnology Development Fund IV, LP | Fund | unknown | Wound down | $960,378 Nov 22, 2019 | 36 | unknown | unknown |
| Vivo Ventures Fund V, LP | Fund | unknown | Wound down | $942,564 Mar 31, 2022 | 45 | unknown | unknown |
| Biotechnology Development Fund, LP | Fund | unknown | Wound down | $471,763 Mar 29, 2017 | 7 | unknown | unknown |
| BDF IV Annex Fund, LP | Continuation vehicle | unknown | Wound down | $244,252 Nov 22, 2019 | 19 | unknown | unknown |
| Biotechnology Development Fund IV Affiliates, LP | Feeder or parallel | unknown | Wound down | $127,612 Nov 22, 2019 | 6 | unknown | unknown |
| Vivo Ventures VI Affiliates Fund, LP | Feeder or parallel | unknown | Wound down | $100,074 Apr 28, 2023 | 39 | unknown | unknown |
| Vivo Ventures V Affiliates Fund, LP | Feeder or parallel | unknown | Wound down | $36,607 Mar 31, 2022 | 41 | unknown | unknown |
| Bioasia Crossover Fund, LP | Growth fund | unknown | Wound down | $0 Mar 27, 2013 | 1 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
31 current, 3 departed
Michael Chan
AnalystAnalyst
Head Trader
AssociateAlbert joined Vivo Capital in 2017 and is a member of the investment team.
Wenping Zhou
AssociateAssociate
Mahendra G. Shah
Board or advisoryAdvisor
Brad Sunderland
Investor relationsAssociate, Investor Relations
Jane Gong
Investor relationsPrincipal, Investor Relations
Edgar Engleman
Managing partnerManaging Partner · since Jun 1, 2005
Edgar G. Engleman
Managing partnerManaging Partner
Frank Kung
Managing partnerManaging Partner · since Jun 1, 2005
Gaurav Aggarwal
Managing partnerManaging Partner
Jack Bech Nielsen
Managing partnerManaging Partner · since Jan 1, 2021
Michael J. Chang
Managing partnerManaging Partner · since Jan 1, 2021
Shan No Middle Name Fu
Managing partnerManaging Partner · since Jan 1, 2015
Mike Preigh
Operating partnerOperating Partner
Chen Meng
PartnerManaging Director
David Liu
PartnerPartner
Hao Dong
PartnerManaging Director
Zhanping Wu
PartnerPartner
Cinthia Sheu
Platform and operationsPartner / Chief Operating Officer · since Apr 1, 2008
Zhanping (nmn) Wu
Platform and operationsPartner / General Counsel / Chief Compliance Officer · since Nov 1, 2019
Albert Chang
PrincipalExecutive Director
Andrew Huang
PrincipalPrincipal
Jiawei Liu
PrincipalPrincipal
Linus Tan
PrincipalPrincipal
Mike Lu
PrincipalPrincipal
Sean Zhang
PrincipalExecutive Director
Timothy Stubbs
PrincipalExecutive Director
Xiaoyang Li
PrincipalPrincipal
Jo Shen
Venture partnerVenture Partner
Yuh-geng Tsay
Venture partnerVenture Partner
Zoe Zhang
Vice presidentSenior Associate
3 departed (kept with end dates)
- Albert Cha · Managing Partner · Jun 1, 2005 to Sep 9, 2020 Inference
- Chen Ming Yu · Managing Partner · Jan 1, 2015 to Aug 31, 2020 Inference
- Hongbo (nmn) Lu · Managing Partner · Jan 1, 2021 to Mar 28, 2024 Inference
Investments on record
76 edges, 75 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
19 relationships from shared deals, counted for the whole firm
Avoro Capital Advisors LLC 5 shared · strongRA Capital Management, LP 2 shared · recurringDecheng Capital LLC 2 shared · recurringFemhealth Ventures Management LLC 1 shared · one timeAvego Management, LLC 1 shared · one timeMission Biocapital 1 shared · one timeSofinnova Partners 1 shared · one timeNEA: New Enterprise Associates 1 shared · one timeArch Venture Partners 1 shared · one timeLongitude Capital Management Co., LLC 1 shared · one timeAdjuvant Capital, LP 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeWindham Venture Partners 1 shared · one timeSpruce Capital Partners 1 shared · one timeVida Ventures 1 shared · one timeQiming 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeBeijing Medical 1 shared · one time · they led 1 · we led 1Health Care Industry Investment Fund 1 shared · one time · they led 1 · we led 1
Limited partners
4 disclosed
- New York State Common Retirement Fund in Vivo Opportunity Fund, L.P. $100M osc.ny.gov
- California State Teachers' Retirement System in Vivo Capital Fund Ix, L.P. $100M calstrs.com
- California State Teachers' Retirement System in Vivo Capital Fund Viii, L.P. $40.0M calstrs.com
- California State Teachers' Retirement System in Vivo Capital Surplus Fund Viii, L.P. $6.0M calstrs.com
Timeline
53 dated events
- Mar 28, 2024Hongbo (nmn) Lu (Managing Partner) no longer on Schedule A of Vivo Capital, LLC
- Mar 28, 2024Vivo Ventures VI Affiliates Fund, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Ventures VI Affiliates Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024Vivo Co-Invest (c), L.P. first reported on Form ADV by Vivo Capital, LLC (Private Equity Fund), GAV $150,000,000Fund first reported on Form ADVFundsFactVivo Co-Invest (c), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024Vivo Capital Fund X, L.P. first reported on Form ADV by Vivo Capital, LLC (Private Equity Fund), GAV $547,959,184Fund first reported on Form ADVFundsFactVivo Capital Fund X, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024Vivo Ventures Fund VI, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Ventures Fund VI, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Opportunity Fund, L.P. no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Opportunity Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Innovation Fund II, L.P. no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Innovation Fund II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Ventures V Affiliates Fund, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Ventures V Affiliates Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Co-Invest (s), L.P. first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $50,004,383Fund first reported on Form ADVFundsFactVivo Co-Invest (s), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Innovation Fund II Holdings, L.P first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $362,688,310Fund first reported on Form ADVFundsFactVivo Innovation Fund II Holdings, L.PSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Opportunity Fund Holdings, L.P. first reported on Form ADV by Vivo Capital, LLC (Other Private Fund), GAV $661,397,218Fund first reported on Form ADVFundsFactVivo Opportunity Fund Holdings, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Asia Opportunity Fund Holdings, L.P. first reported on Form ADV by Vivo Capital, LLC (Other Private Fund), GAV $158,004,158Fund first reported on Form ADVFundsFactVivo Asia Opportunity Fund Holdings, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Ventures Fund V, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Ventures Fund V, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Vivo Asia Opportunity Fund, L.P. no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Asia Opportunity Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Vivo Asia Opportunity Fund, L.P. first reported on Form ADV by Vivo Capital, LLC (Private Equity Fund), GAV $105,381,862Fund first reported on Form ADVFundsFactVivo Asia Opportunity Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Vivo Opportunity Co-Invest (w), L.P. no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceVivo Opportunity Co-Invest (w), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Vivo Innovation Fund II, L.P. first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund)Fund first reported on Form ADVFundsFactVivo Innovation Fund II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2021Hongbo (nmn) Lu joined Schedule A of Vivo Capital, LLC as Managing Partner
- Jan 1, 2021Jack Bech Nielsen joined Schedule A of Vivo Capital, LLC as Managing Partner
- Jan 1, 2021Michael J. Chang joined Schedule A of Vivo Capital, LLC as Managing Partner
- Sep 9, 2020Albert (nmn) Cha (Managing Partner) no longer on Schedule A of Vivo Capital, LLC
- Aug 31, 2020Chen Ming Yu (Managing Partner) no longer on Schedule A of Vivo Capital, LLC
- Mar 27, 2020BDF IV Annex Fund, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceBDF IV Annex Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020Biotechnology Development Fund IV, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceBiotechnology Development Fund IV, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020Biotechnology Development Fund IV Affiliates, LP no longer reported on Form ADV by Vivo Capital, LLC
- Mar 27, 2020Biotechnology Development Fund II, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceBiotechnology Development Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020Vivo Opportunity Co-Invest, L.P. first reported on Form ADV by Vivo Capital, LLC (Private Equity Fund), GAV $94,766,777Fund first reported on Form ADVFundsFactVivo Opportunity Co-Invest, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020Vivo Opportunity Co-Invest (w), L.P. first reported on Form ADV by Vivo Capital, LLC (Private Equity Fund), GAV $23,700,528Fund first reported on Form ADVFundsFactVivo Opportunity Co-Invest (w), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 1, 2019Zhanping (nmn) Wu joined Schedule A of Vivo Capital, LLC as General Counsel / Chief Compliance Officer
- Mar 29, 2019Vivo Capital Fund Ix, L.P. first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $879,107,034Fund first reported on Form ADVFundsFactVivo Capital Fund Ix, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2019Vivo Super Viii Limited first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $162,559,245Fund first reported on Form ADVFundsFactVivo Super Viii LimitedSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2018Vivo Opportunity Fund, L.P. first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $395,757,576Fund first reported on Form ADVFundsFactVivo Opportunity Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2018Biotechnology Development Fund, LP no longer reported on Form ADV by Vivo Capital, LLCFund no longer reportedFundsInferenceBiotechnology Development Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 30, 2016Vivo Panda Fund, LP first reported on Form ADV by Vivo Capital, LLC (Venture Capital Fund), GAV $100,306,122Fund first reported on Form ADVFundsFactVivo Panda Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 26, 2015Vivo Capital Surplus Fund Viii, L.P. first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $30,612,245Fund first reported on Form ADVFundsFactVivo Capital Surplus Fund Viii, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 26, 2015Vivo Capital Fund Viii, L.P. first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $405,765,306Fund first reported on Form ADVFundsFactVivo Capital Fund Viii, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2015Chen Ming Yu joined Schedule A of Vivo Capital, LLC as Managing Partner
- Jan 1, 2015Shan No Middle Name Fu joined Schedule A of Vivo Capital, LLC as Managing Partner
- Mar 28, 2014Bioasia Crossover Fund, LP no longer reported on Form ADV by Vivo Ventures, LLCFund no longer reportedFundsInferenceBioasia Crossover Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures VI Affiliates Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $2,597,597Fund first reported on Form ADVFundsFactVivo Ventures VI Affiliates Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures V Affiliates Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $2,226,765Fund first reported on Form ADVFundsFactVivo Ventures V Affiliates Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures Fund V, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $169,750,090Fund first reported on Form ADVFundsFactVivo Ventures Fund V, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures VII Affiliates Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $6,468,289Fund first reported on Form ADVFundsFactVivo Ventures VII Affiliates Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Biotechnology Development Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $2,674,802Fund first reported on Form ADVFundsFactBiotechnology Development Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012BDF IV Annex Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $13,014,306Fund first reported on Form ADVFundsFactBDF IV Annex Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures Fund VI, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $345,869,821Fund first reported on Form ADVFundsFactVivo Ventures Fund VI, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Biotechnology Development Fund II, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $4,967,726Fund first reported on Form ADVFundsFactBiotechnology Development Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Biotechnology Development Fund IV Affiliates, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $382,376Fund first reported on Form ADVFundsFactBiotechnology Development Fund IV Affiliates, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Bioasia Crossover Fund, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $4,015,539Fund first reported on Form ADVFundsFactBioasia Crossover Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Biotechnology Development Fund IV, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $15,014,766Fund first reported on Form ADVFundsFactBiotechnology Development Fund IV, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures Fund VII, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $293,990,105Fund first reported on Form ADVFundsFactVivo Ventures Fund VII, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2012Vivo Ventures Fund Cayman VII, LP first reported on Form ADV by Vivo Ventures, LLC (Venture Capital Fund), GAV $77,385,902Fund first reported on Form ADVFundsFactVivo Ventures Fund Cayman VII, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Multi-stage venture firm (probable, 80%, cls-1)both early and growth/opportunity families, reported GAV $6,018M
Evidence
60 observations from 3 sources